Aptamer Moieties in Biochemical Applications

  • Michael J. Donovan
  • , Ling Meng
  • , Basri Gulbakan
  • , Yan Chen
  • , Parag Parekh
  • , Kwame Sefah
  • , Weihong Tan

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Aptamers developed for applications in cancer therapy can improve the efficacy of drug treatment and enhance imaging. Aptamers for these purposes are generated from a process known as SELEX (systematic evolution of ligands by exponential enrichment), or, more precisely when biological cells are used, cell-based SELEX. Aptamers provide a highly target-specific means of transporting drugs to cancer cells. Improved imaging is also possible when aptamers are coupled with micelles, nanomaterials, or hydrogels. These aptamer conjugates show great ability as molecular probes in a variety of applications.

Original languageEnglish
Title of host publicationSupramolecular Chemistry
Publisherwiley
Pages1-8
Number of pages8
ISBN (Electronic)9780470661345
ISBN (Print)9780470746400
DOIs
Publication statusPublished - 1 Jan 2012
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • aptamers
  • cancer cells
  • conjugation
  • drug development
  • molecular conjugate

Fingerprint

Dive into the research topics of 'Aptamer Moieties in Biochemical Applications'. Together they form a unique fingerprint.

Cite this